A new drug in development for metabolic diseases could also benefit people with chronic myeloid leukaemia (CML).
Researchers found that targeting CML cells with MSDC-0160, a drug being tested for type 2 diabetes and Alzheimer’s disease, weakened t...
8 months ago
Researchers have identified factors that predict long-term outlook for people with AL amyloidosis.
This condition, also known as light chain amyloidosis, is a rare disease involving deposits of abnormal amyloid protein that accumulates in tissues...
8 months ago
